0001654954-23-009402.txt : 20230719 0001654954-23-009402.hdr.sgml : 20230719 20230719160332 ACCESSION NUMBER: 0001654954-23-009402 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230717 FILED AS OF DATE: 20230719 DATE AS OF CHANGE: 20230719 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SPINK KENNETH B. CENTRAL INDEX KEY: 0001652627 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22893 FILM NUMBER: 231096715 MAIL ADDRESS: STREET 1: C/O AEHR TEST SYSTEMS STREET 2: 400 KATO TERRACE CITY: FREMONT STATE: CA ZIP: 94539 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AEHR TEST SYSTEMS CENTRAL INDEX KEY: 0001040470 STANDARD INDUSTRIAL CLASSIFICATION: INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS [3825] IRS NUMBER: 942424084 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 KATO TERRACE CITY: FREMONT STATE: CA ZIP: 94539 BUSINESS PHONE: 5106239400 MAIL ADDRESS: STREET 1: 400 KATO TERRACE CITY: FREMONT STATE: CA ZIP: 94539 4 1 section16.xml PRIMARY DOCUMENT X0508 4 2023-07-17 0001040470 AEHR TEST SYSTEMS AEHR 0001652627 SPINK KENNETH B. C/O AEHR TEST SYSTEMS 400 KATO TERRACE FREMONT CA 94539 true VP of Finance and CFO false Common Stock 2023-07-17 4 M false 11511 2.4000 A 11511 D Common Stock 2023-07-17 4 M false 25000 1.6350 A 36511 D Common Stock 2023-07-17 4 S false 36511 51.3949 D 0 D Common Stock 109866 I by Trust Incentive Stock Option (right to buy) 1.6350 2023-07-17 4 M false 25000 0 D 2019-08-16 2026-07-16 Common Stock 25000 0 D Incentive Stock Option (right to buy) 2.4 2023-07-17 4 M false 11511 0 D 2018-09-17 2025-08-17 Common Stock 11511 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.25 to $51.75, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. The amount reported includes shares subject to unvested restricted stock units. One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. /s/ Kenneth B. Spink 2023-07-19